Live Breaking News & Updates on Cov Igg

Stay updated with breaking news from Cov igg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

Researchers found biphasic peaks of MERS-CoV in dromedaries in Kenya, with evidence of serologic exposure among slaughterhouse workers, highlighting potential human transmission risks. ....

Adis Abeba , Emerging Infectious Diseases , Middle East , Cov Incidence , Nomadic Dromedaries , Putative Transmission , Arabian Peninsula , Cov Igg , Mers Cov , Infectious Diseases , Ars Cov 2 ,

Immune response after mild COVID

In a recent study posted to the medRxiv preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ....

San Diego , United States , Maglumi Snibe , Diasorin Snibe , Snibe Co Ltd , Epitope Diagnostics Inc , Cov Igg ,

Cureus | SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal

At the time of the first wave of the COVID-19 pandemic, patients with cancer were considered to be at high risk of serious illness and had a higher exposure risk since they needed frequent and nondeferrable hospital visits. Serological tests were not routinely used, and seroprevalence in this population was unknown.

A single-center, cross-sectional study was developed to determine the seroprevalence of anti-SARS-CoV-2 antibodies (Abs) in patients with cancer undergoing systemic antineoplastic treatment. One hundred patients were consecutively recruited in a two-week period (6th-20th May 2020), and serum samples were tested for the presence of immunoglobulin M (IgM) and immunoglobulin G (IgG) Abs directed against both spike (S) and nucleocapsid (N) SARS-CoV-2 proteins in two distinct time points (at recruitment and 4-8 weeks later). IgG-positive results were subject to confirmation, in the same serum sample, using two distinct assays.

At the time of the first study visit, ....

United States , Portuguese Health Authority , Portuguese National Health Authority , Hospital Da Luz Lisboa Ethics Committee , Eastern Cooperative Oncology Group , Luz Lisboa Ethics Committee , Medical Oncology Unit , Igg Abs , Cov Igg , Igg Abbott Architect , Abbott Diagnostics , Oncology Unit , Luz Lisboa , Performance Status , Abbott Architect , Day Hospital ,